NO783471L - Xantinderivater og fremgangsmaate til deres fremstilling - Google Patents

Xantinderivater og fremgangsmaate til deres fremstilling

Info

Publication number
NO783471L
NO783471L NO783471A NO783471A NO783471L NO 783471 L NO783471 L NO 783471L NO 783471 A NO783471 A NO 783471A NO 783471 A NO783471 A NO 783471A NO 783471 L NO783471 L NO 783471L
Authority
NO
Norway
Prior art keywords
procedures
preparation
xantine
derivatives
xantine derivatives
Prior art date
Application number
NO783471A
Other languages
English (en)
Other versions
NO147562B (no
NO147562C (no
Inventor
Sten Haakan Axel Ma Bergstrand
Per Gunnar Kjellin
Carl Goeran August Persson
Lars Magnus Soerenby
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO783471L publication Critical patent/NO783471L/no
Publication of NO147562B publication Critical patent/NO147562B/no
Publication of NO147562C publication Critical patent/NO147562C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO783471A 1977-10-14 1978-10-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater NO147562C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7711581A SE416810C (sv) 1977-10-14 1977-10-14 Forfarande for framstellning av xantinderivat med antiallergisk aktivitet

Publications (3)

Publication Number Publication Date
NO783471L true NO783471L (no) 1979-04-18
NO147562B NO147562B (no) 1983-01-24
NO147562C NO147562C (no) 1983-05-18

Family

ID=20332576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO783471A NO147562C (no) 1977-10-14 1978-10-13 Analogifremgangsmaate for fremstilling av terapeutisk virksomme xantinderivater

Country Status (21)

Country Link
US (1) US4233303A (no)
EP (1) EP0001735B1 (no)
JP (1) JPS5479296A (no)
AT (1) AT363491B (no)
AU (1) AU521585B2 (no)
CA (1) CA1109470A (no)
CS (1) CS208756B2 (no)
DD (1) DD139855A5 (no)
DE (1) DE2862017D1 (no)
DK (1) DK148260C (no)
FI (1) FI66383C (no)
HK (1) HK6385A (no)
HU (1) HU180219B (no)
IE (1) IE47884B1 (no)
IT (1) IT1109208B (no)
NO (1) NO147562C (no)
NZ (1) NZ188566A (no)
SE (1) SE416810C (no)
SG (1) SG85584G (no)
SU (1) SU755199A3 (no)
ZA (1) ZA785335B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
SE8002910L (sv) * 1980-04-18 1981-10-19 Draco Ab 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar
US4755517A (en) * 1986-07-31 1988-07-05 Warner-Lambert Company Derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
GB8929208D0 (en) * 1989-12-27 1990-02-28 Almirall Lab New xanthine derivatives
US5047534A (en) * 1990-03-26 1991-09-10 Merrell Dow Pharmaceuticals Inc. Selective adenosine receptor agents
US5342841A (en) * 1992-03-12 1994-08-30 Kyowa Hakko Kogyo Co., Ltd. Xanthine derivatives
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
US5395836A (en) * 1993-04-07 1995-03-07 Kyowa Hakko Kogyo Co., Ltd. 8-tricycloalkyl xanthine derivatives
GB9312853D0 (en) * 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) * 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US5661153A (en) * 1994-07-19 1997-08-26 Japan Energy Corporation 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE247116T1 (de) * 1994-12-13 2003-08-15 Euro Celtique Sa Arylthioxanthine
EP0799040B1 (en) * 1994-12-13 2003-08-20 Euroceltique S.A. Trisubstituted thioxanthines
US6166041A (en) * 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) * 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
US5864037A (en) 1996-06-06 1999-01-26 Euro-Celtique, S.A. Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
CA2522971A1 (en) 2003-04-25 2004-11-11 Novacardia, Inc. Method of improved diuresis in individuals with impaired renal function
KR20070008689A (ko) * 2004-04-16 2007-01-17 노바카르디아, 인코포레이션 아데노신 ａ１ 수용체 길항제 및 알도스테론 억제제를포함하는 병용 요법
US20070049757A1 (en) * 2005-08-26 2007-03-01 Rieger Jayson M Methods for the synthesis of substituted amino uracils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen
US3900474A (en) * 1973-05-14 1975-08-19 Kendall & Co Trifluoroalkyl, fluorobenzyl, pentafluorobenzyl, fluorobenzenesulfonyl, and pentafluorobenzenesulfonyl theophyllines
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
CA1077932A (en) 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
US4120947A (en) * 1976-03-31 1978-10-17 Cooper Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases

Also Published As

Publication number Publication date
AT363491B (de) 1981-08-10
EP0001735A1 (en) 1979-05-02
SE416810C (sv) 1982-07-19
JPS5479296A (en) 1979-06-25
IE47884B1 (en) 1984-07-11
IE782041L (en) 1979-04-14
US4233303A (en) 1980-11-11
HU180219B (en) 1983-02-28
FI783126A (fi) 1979-04-15
FI66383B (fi) 1984-06-29
IT1109208B (it) 1985-12-16
AU521585B2 (en) 1982-04-22
DK453778A (da) 1979-04-15
HK6385A (en) 1985-02-01
NO147562B (no) 1983-01-24
IT7851499A0 (it) 1978-10-13
CA1109470A (en) 1981-09-22
SU755199A3 (en) 1980-08-07
AU4036578A (en) 1980-04-17
DK148260C (da) 1986-02-10
NO147562C (no) 1983-05-18
SG85584G (en) 1985-06-07
EP0001735B1 (en) 1982-09-01
ZA785335B (en) 1979-09-26
DE2862017D1 (en) 1982-10-28
FI66383C (fi) 1984-10-10
ATA714478A (de) 1980-09-15
DK148260B (da) 1985-05-20
CS208756B2 (en) 1981-09-15
SE416810B (sv) 1981-02-09
DD139855A5 (de) 1980-01-23
NZ188566A (en) 1984-07-06
SE7711581L (sv) 1979-04-15

Similar Documents

Publication Publication Date Title
NO783471L (no) Xantinderivater og fremgangsmaate til deres fremstilling
NO781130L (no) Cephemderivater og fremgangsmaate til deres fremstilling
DK495476A (da) Phenolethere og fremgangsmade til deres fremstilling
DK338379A (da) Pyrazinderivater og fremgangsmaade til deres fremstilling
DK214688A (da) Cycliske imider og fremgangsmaade til deres fremstilling
DK145276A (da) Erythromycinderivater og fremgangsmade til deres fremstilling
DK557876A (da) Polyhalogensteroider og fremgangsmade til deres fremstilling
DK522578A (da) G prostacyklinderivater og fremgangsmaade til deres fremstillin
DK547378A (da) 1-n-4,6-di-o(aminoglycosyl-)-1,3-dimino-cyclitol-derivater deres fremstilling og anvendelse
DK150778A (da) Prostanderivater og fremgangsmaade til fremstilling heraf
DK495578A (da) Quinazolderivater og fremgangsmaade til fremstilling deraf
NO780800L (no) Azoforbindelser og fremgangsmaate til deres fremstilling
DK339078A (da) Neuromuskulaere blokeringsmidler og fremgangsmaade til deres fremstilling
DK409277A (da) Pentapeptider og fremgangsmaade til deres fremstilling
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
DK582578A (da) 2,4-thiazolidindion-derivater og fremgangsmaade til deres fremstilling
DK31576A (da) Acetylenderivater og fremgangsmade til deres fremstilling
DK111678A (da) Enzym-marumer og fremgangsmaade til deres fremstilling
DK416278A (da) 2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK161377A (da) Naphtyridinderivater og fremgangsmade til deres fremstilling
DK341576A (da) Homophthalimider og fremgangsmade til deres fremstilling
DK319478A (da) Angiotensinpeptider og deres fremstilling
NO784128L (no) Nye tetrapeptider og fremgangsmaate til deres fremstilling
DK344677A (da) Antracyklinetrar og fremgangsmade for deres fremstilling
DK323378A (da) Imidazo-isoquinolin-dioner og fremgangsmaade til deres fremstilling